At 9.1% CAGR, the North America Swine Diagnostics Market is Projected to be worth US$ 121.35 million by 2030, says Business Market Insights

According to Business Market Insights research, the North America swine diagnostics market was valued at US$ 60.38 million in 2022 and is expected to reach US$ 121.35 million by 2030, registering a CAGR of 9.1% from 2022 to 2030. Increasing prevalence of swine diseases and favorable government initiatives are the critical factors attributed to the North America swine diagnostics market expansion.               

According to the World Organization for Animal Health (OIE), over 100 million cases of pig diseases were reported worldwide in 2021. The most common pig diseases were African swine fever, swine influenza, porcine reproductive and respiratory syndrome (PRRS), pseudorabies, and enzootic pneumonia of pigs. Additionally, in the US, the OIE estimates that approximately 70% of pig herds are infected with Porcine reproductive and respiratory syndrome. Thus, the rising prevalence of various swine diseases boosts the swine diagnostic market worldwide.  

On the contrary, high costs involved in pork health maintenance hurdles the growth of North America industrial robotics market.

Based on product type, the North America swine diagnostics market is segmented into immunoassays kits, PCR kits, hemagglutination inhibition (HI), and others. The immunoassays kits segment held 44.1% share of North America swine diagnostics market in 2022, amassing US$ 26.63 million. It is projected to garner US$ 55.74 million by 2030 to expand at 9.7% CAGR during 2022–2030.

Based on sample type, the North America swine diagnostics market is segmented into blood, oral fluids, nasal swabs, tissue samples, and others. The blood segment held 40.7% share of North America swine diagnostics market in 2022, amassing US$ 24.54 million. It is projected to garner US$ 51.95 million by 2030 to expand at 9.8% CAGR during 2022–2030.

Based on disease, the North America swine diagnostics market is segmented into African swine fever (ASF)/classical swine fever (CSF), respiratory diseases, porcine circovirus, porcine epidemic diarrhea, swine dysentery, and others. The African swine fever (ASF)/classical swine fever (CSF) segment held 32.7% share of North America swine diagnostics market in 2022, amassing US$ 19.77 million. It is projected to garner US$ 40.68 million by 2030 to expand at 9.4% CAGR during 2022–2030.  

Based on end user, the North America swine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end users. The veterinary hospitals segment held 61.1% share of North America swine diagnostics market in 2022, amassing US$ 36.92 million. It is projected to garner US$ 75.30 million by 2030 to expand at 9.3% CAGR during 2022–2030.

Based on country, the North America swine diagnostics market is segmented into the US, Canada, Mexico. Our regional analysis states that the US captured 82.4% share of North America swine diagnostics market in 2022. It was assessed at US$ 49.75 million in 2022 and is likely to hit US$ 101.02 million by 2030, exhibiting a CAGR of 9.3% during 2022–2030.  

Key players operating in the North America swine diagnostics market are BioCheck BV, Bionote Inc, Idexx Laboratories Inc, INDICAL BIOSCIENCE GmbH, Innovative Diagnostics SAS, Neogen Corp, Ring Biotechnology Co Ltd, SAN Group GmbH, Thermo Fisher Scientific Inc, and Zoetis Inc, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com